CardioDx

edit

CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure.

Milestones

edit

• 
  CardioDx received $20M in Series D funding. (8/31/09)
  Posted 9/24/09 at 2:52pm

Videos

Screenshots

edit

Above: CardioDx
Uploaded: 10/16/09

Sources

1. Cap Funding Report [edit]